Suppr超能文献

色甘酸钠治疗慢性持续性溃疡性结肠炎的对照试验

Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

作者信息

Buckell N A, Gould S R, Day D W, Lennard-Jones J E, Edwards A M

出版信息

Gut. 1978 Dec;19(12):1140-3. doi: 10.1136/gut.19.12.1140.

Abstract

Oral disodium cromoglycate (200 mg qds) has been tested in 26 patients with ulcerative colitis that was resistant to medical treatment. In a double-blind crossover trial disodium cromoglycate and placebo were added to conventional treatment in random order, each for four weeks. There was no significant difference in therapeutic effect between disodium cromoglycate and placebo.

摘要

口服色甘酸钠二钠(200毫克,每日四次)已在26例对药物治疗有抵抗性的溃疡性结肠炎患者中进行了测试。在一项双盲交叉试验中,色甘酸钠二钠和安慰剂以随机顺序添加到常规治疗中,各为期四周。色甘酸钠二钠和安慰剂之间的治疗效果没有显著差异。

引用本文的文献

1
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.
Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD011572. doi: 10.1002/14651858.CD011572.pub2.
2
Meta-analysis of the placebo response in ulcerative colitis.
Dig Dis Sci. 2008 Apr;53(4):875-91. doi: 10.1007/s10620-007-9954-6. Epub 2007 Oct 13.
4
Ketotifen therapy for acute ulcerative colitis in children: a pilot study.
Dig Dis Sci. 1998 Mar;43(3):609-15. doi: 10.1023/a:1018827527826.
5
Assessment of drug therapy in inflammatory bowel disease.
Br J Clin Pharmacol. 1982 Aug;14(2):159-70. doi: 10.1111/j.1365-2125.1982.tb01957.x.
7
Treatment of ulcerative colitis.
Br Med J (Clin Res Ed). 1981 Apr 18;282(6272):1255-6.
9
Treatment of pyoderma gangrenosum with disodium cromoglycate.
Dig Dis Sci. 1984 Feb;29(2):183-5. doi: 10.1007/BF01317063.
10
The mucosal mast cell and its role in gastrointestinal allergic diseases.
Clin Rev Allergy. 1984 Feb;2(1):39-53. doi: 10.1007/BF02991210.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验